US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 10, 2022 (4 years ago)

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations: deviations leading to potential cross-contamination.

What was recalled

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron Pharmaceutical Corporation 4500 12th Street Extension West Columbia, SV 29172, NDC 0487-6232-01

Recalling firm
Nephron Sc Inc
NDC code
0487-6232-01
Origin
SC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1354-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ketorolac recalls

See all